<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1226">
  <stage>Registered</stage>
  <submitdate>21/04/2006</submitdate>
  <approvaldate>27/04/2006</approvaldate>
  <actrnumber>ACTRN12606000143527</actrnumber>
  <trial_identification>
    <studytitle>MINIMI Study</studytitle>
    <scientifictitle>MINIMI Multi-centre study. Minimising blood loss during blood testing from intra-arterial catheters in intensive care patients</scientifictitle>
    <utrn />
    <trialacronym>MINIMI</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Intensive care patients requiring blood tests from an intra-arterial catheter</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The study is a randomised crossover trial. Patients are randomised to a sequence of blood tests which are taken sequentially.                                                                                                   The intervention is the size of discard volume (blood discarded to clear the line).                                                                                                                                                                                    This is calculated as a multiple of the deadspace in the system prior to blood sampling. Six discard volumes will be tested. Each patient acts as their own control and receives each of the experiemental discard volumes.                                                                                                                                                                                                                                       Duration: The blood sampling for the study is done on one occasion with 48 sequential blood tests (6 each of full blood count, creatinine &amp; electrolytes, liver functions, coagulation, magnesium, troponin, calcium, &amp; phosphate. The process will be completed within 10 minutes.                                                                                                                                                    Timepoint: At some stage of the intensive care admission when the patient meets the study criteria and samples can be obtained without disrupting clinical care.</interventions>
    <comparator>patient is own control, different discard volumes are used for each set of blood tests</comparator>
    <control>Active</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Accuracy of full blood count</outcome>
      <timepoint>immediately after blood sampling</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Accuracy of creatine and electrolytes</outcome>
      <timepoint>immediately after blood sampling</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>immediately after blood sampling</outcome>
      <timepoint>immediately after blood sampling</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Accuracy of coagulation studies</outcome>
      <timepoint>immediately after blood sampling</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Accuracy of magnesium, phosphate and calcium</outcome>
      <timepoint>immediately after blood sampling</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Accuracy of troponin</outcome>
      <timepoint>immediately after blood sampling</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Develop model to minimise blood loss in ICU patients from diagnostic testing. </outcome>
      <timepoint>This will be done during the data analysis phase.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Informed written consent from patient or legal representative Patent arterial catheter in situ as part of routine care  Haemoglobin &gt;8.0g/dL Clinically stable (has neither required nor is anticipated to require any intervention in the 30 minutes prior to, or during the sampling period).</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Current bleeding or major surgery planned in the next 48 hours Current transfusion of blood products, hypertonic electrolytes, or anticoagulants other than heparin saline in flush devices Patient with extracorporeal circuits Non-English speaking patient or legal representative Patient not expected to survive the next 24 hours or patient/relatives deemed too emotionally distressed to be approached Inotrope support exceeding Nor-Adrenaline and Adrenaline &gt; 5mcg/min, Dopamine and Dobutamine &gt; 5mcg/kg/min.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Dummy times recorded on pathology forms</concealment>
    <sequence>Computer generated random numbers</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/04/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Griffith University School of Nursing and Midwifery</primarysponsorname>
    <primarysponsoraddress>School of Nursing and Midwifery
Griffith University Nathan Campus Kessels Rd Nathan QLD 4111
Newnham Campus</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>ICU Departments of Launceston General Hospital</fundingname>
      <fundingaddress>Charles St, Launceston 7250 TAS</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal Prince Alfred Hospital</fundingname>
      <fundingaddress>Sydney NSW</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Sir Charles Gairdner Hospital</fundingname>
      <fundingaddress>Hospital Drive, NEDLANDS, WA</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Uni of Tasmania School of Nursing and Midwifery</fundingname>
      <fundingaddress>Newnham Campus TAS 7250</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Clifford Craig Medical Research Trust</fundingname>
      <fundingaddress>PO Box 1963. Launceston, 7250 Tasmania</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Griffith University</fundingname>
      <fundingaddress>170 Kessels Rd, Nathan, QLD</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Launceston General Hospital</sponsorname>
      <sponsoraddress>Charles St Launceston TAS 7250</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>ICU Departents:Royal Prince Alfred Hospital</sponsorname>
      <sponsoraddress>Sydney NSW</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>ICU Departents: Sir Charles Gairdner Hospital</sponsorname>
      <sponsoraddress>Nedlands WA</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Charities/Societies/Foundations</sponsortype>
      <sponsorname>Clifford Craig Medical Research Trust Fund</sponsorname>
      <sponsoraddress>PO Box 1963 Launceston TAS 7250.</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Intensive care patients require many blood tests. Each blood test requires a small amount of blood loss and when added together this can lead to anaemia and the need for a blood transfusion. ICU blood tests are taken through a drip, and an amount of blood must be wasted each time, to clear the drip set and access the patients blood. This discard volume is important: too little and the blood tests may be inaccurate, too much and the patient loses even more blood unnecessarily. The ideal discard volume for most blood tests is unknown and so hospitals and health professionals take various amounts; it is highly likely that unnecessary blood loss occurs. 

In our study we plan to identify the minimum discard volume required to obtain accurate results for several of the most common blood tests performed in ICUs. The laboratory scientists (assessors) performing the outcomes measures will be blinded to intervention group of each blood sample.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Tasmanian State Health Research Ethics Committee</ethicname>
      <ethicaddress>University of Tasmania
Sandy Bay Campus Hobart Tas</ethicaddress>
      <ethicapprovaldate>20/02/2006</ethicapprovaldate>
      <hrec>H0008638.</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Royal Prince Alfred Hospital</ethicname>
      <ethicaddress>Sydney NSW</ethicaddress>
      <ethicapprovaldate>7/12/2005</ethicapprovaldate>
      <hrec>X05-0354</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Sir Charles Gairdner Hospital</ethicname>
      <ethicaddress>Hospital Drive Nedlands, WA</ethicaddress>
      <ethicapprovaldate>16/03/2006</ethicapprovaldate>
      <hrec>2006-001</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Prof Claire Rickard</name>
      <address>Research Centre for Clinical and Community Practice Innovation
Griffith University
Nathan Campus QLD 4111</address>
      <phone>61 7 3735 6460</phone>
      <fax />
      <email>c.rickard@griffith.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof Claire Rickard</name>
      <address>Research Centre for Clinical and Community Practice Innovation
Griffith University, Nathan Campus, QLD</address>
      <phone>61 7 3735 6460</phone>
      <fax />
      <email>c.rickard@griffith.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof Claire Rickard</name>
      <address />
      <phone />
      <fax />
      <email>c.rickard@griffith.edu.au</email>
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>